At a Glance
On June 19, Samsung Electronics took part in VivaTech 2026 — Europe's largest startup and tech expo, held in Paris, France — where it unveiled "Connected Care," a healthcare vision grounded in open collaboration. Rather than a one-off exhibition event, this looks more like a medium- to long-term move to grow wearables and digital health into new revenue streams amid slowing smartphone growth. From an investor's perspective, the key is to read the signal that Samsung is shifting its center of gravity from hardware sales toward subscriptions, data, and services.
Why It Matters Now
Behind Samsung's decision to put collaboration front and center lies a structural reality: healthcare cannot be completed by any single company's devices alone. Health data such as blood pressure, blood glucose, and sleep only translates into real services when measurement devices, medical stakeholders (hospitals and insurers), and regulatory approvals all come together. The open-ecosystem strategy can be read as an attempt by Samsung — instead of taking on every domain itself — to make its own measurement platforms like the Galaxy Watch and Ring a standard hub, drawing in external medical and startup data.
The rationale on the demand side is equally clear. As aging populations and the need for chronic disease management grow, devices that continuously track everyday health data are becoming more valuable. For Samsung, wearables also serve as a lock-in mechanism that keeps users tied to the Galaxy smartphone ecosystem. In other words, this vision connects not just to healthcare revenue itself, but to a bigger picture of revenue diversification — through device replacement cycles, subscription services, and data-driven value-added services rather than advertising.
That said, the success or failure of this strategy will be decided not by an expo announcement, but by whether regulatory approvals and actual partnerships with medical institutions and insurers materialize. It is worth keeping in mind that a considerable time lag separates the vision-presentation stage from the revenue-contribution stage.
Frequently Asked Questions
- Will Connected Care boost Samsung's earnings right away — Direct near-term contribution is limited. Wearables and service revenue still make up a small share of company-wide revenue, so the memory and smartphone cycles carry far more weight.
- Why emphasize open collaboration — Because medical data, regulation, and diagnostics are hard to handle with in-house capabilities alone. The strategy is to bring in external startups and medical partners to scale the ecosystem quickly.
- What does the competitive landscape look like — Apple leads with watch-centric health features and a closed ecosystem, and Google also competes through Fitbit. Samsung is trying to differentiate itself by leveraging the openness of the Android camp.
- What should investors watch — Concrete medical-device certifications, disclosures of insurer and hospital partnerships, and trends in wearable shipments and service subscribers are the indicators that show whether the vision is being realized.
Impact on Related Stocks and Sectors
- Samsung Electronics — As the driver of this vision, expansion in wearables and digital health could add to its long-term growth story, but near-term earnings are still governed by the memory market.
- Digital healthcare and wearable components sector — If demand for sensors and bio-signal measurement modules rises, a trickle-down effect on related component makers is possible.
- Medical data and telemedicine-related stocks — As the open ecosystem expands, opportunities for data integration and platform collaboration could open up.
- Competitors Apple and Google — Samsung's open strategy is also expected to accelerate competition in the healthcare ecosystem, growing the overall digital health market pie.
Points to Note When Investing
- There is a large time lag between the vision announcement and revenue realization. Caution is needed not to equate an expo message directly with earnings momentum.
- The medical field faces high regulatory and certification barriers that vary by country, so global expansion may be slower than expected.
- Samsung Electronics' share price is fundamentally more sensitive to the semiconductor cycle and the exchange rate, so judging the stock's direction on the healthcare theme alone is risky.
- Tighter health-data security and privacy regulations are a potential cost factor for business expansion.
Overall Outlook
On the optimistic side, Samsung has the potential to layer open healthcare on top of its powerful existing user base — the Galaxy ecosystem — and secure a new pillar of service and data revenue over the long term. On the other hand, medical regulation, Apple's first-mover advantage, and the possibility that the vision fails to translate into actual partnerships and certifications are clear risks. Accordingly, it is reasonable to take this announcement as a signal confirming the direction of Samsung's business diversification, while checking on a quarterly basis whether follow-up certifications and partnership disclosures emerge.
Samsung Electronics in Real-Time Data
The latest closing price of Samsung Electronics is 354,000 won (-2.34% vs. the previous day), and the signal light combining foreign and institutional investor order flow with news and momentum is 🔴 Caution. With foreign investors, institutional investors, and momentum all negative, caution is warranted right now.
- ▼ Dual selling — Foreign investors −899.5 billion won · institutional investors −501.6 billion won, selling in tandem
- ▲ 52-week position — In the upper 94% of the 52-week range — near record-high territory
- ▲ News flow — 27 positive catalysts vs. 6 negative catalysts — positive bias
Recent related news is favorable, with 27 positive catalysts and 6 negative catalysts.
※ Price and foreign/institutional investor order-flow data are provided by Korea Investment & Securities (KIS), as of the time of publication.
This article is content automatically summarized and analyzed based on the original news. View original (Maeil Business Newspaper, Corporate)
